Details

As global health threats become more complex and interconnected, strong biosecurity requires collaboration, innovation, and data-driven insight. At MTX26, Illumina is excited to advance conversations around strengthening national and international biosecurity capabilities.

Illumina brings a proven track record in genomics-driven approaches that support pathogen detection, surveillance, and response. By showcasing how next-generation sequencing (NGS) enables earlier detection and deeper understanding of biological threats, Illumina aims to highlight how genomic data can play a critical role in enhancing public safety, preparedness, and resilience across borders.

At the event, Illumina will demonstrate how genomic surveillance supports biosecurity initiatives by enabling rapid pathogen identification, monitoring emerging threats, and informing faster, more confident public health decisions. These capabilities are increasingly essential for infectious disease research, microbiology, and public health laboratories worldwide.

Attend our science thematic zone presentation or visit the Illumina booth at L1-E20 to see the MiSeq i100 Series up close. Designed for speed and simplicity, the MiSeq i100 brings the power of next-generation sequencing directly into your lab—delivering same‑day results for pathogen identification to support faster responses to emerging threats.

Science Thematic Zone Presentation

Date:

29th April 2026, Wednesday

Time:

1:40 pm - 2:00 pm

Speaker:

Michael Abdo
Business Unit Lead, Strategic Growth APAC - Microbiology, Infectious Disease & Agrigenomics,
Illumina

Talk Title:

Genomics as our early warning system for infectious disease threats

Whether you are strengthening surveillance programs or expanding in‑house sequencing capabilities, discover how the MiSeq i100 Series can help you.

Date & Time
28 Apr. 2026 – 30 Apr. 2026
Location
Sands Expo and Convention Centre
Singapore
South APAC
Visit Website